Expert consensus on the management of chronic lymphocytic leukaemia in Asia

Eric Tse, Yok Lam Kwong, Yeow Tee Goh, Ping Chong Bee, Soo Chin Ng, Daryl Tan, Priscilla Caguioa, Huynh Nghia, Teresita Dumagay, Lalita Norasetthada, Suporn Chuncharunee, Vivek Radhakrishnan, Bhausaheb Bagal, Tubagus Djumhana Atmakusuma, Nadia Ayu Mulansari

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)


In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and guidelines on the management of CLL from an Asian population perspective. This consensus guideline aims to understand treatment challenges and suggest appropriate management approaches for CLL in the Asian population and other countries with a similar socio-economic profile. The following recommendations are based on a consensus by experts and an extensive literature review and contribute towards uniform patient care in Asia.

Original languageEnglish
Pages (from-to)2895-2907
Number of pages13
JournalClinical and Experimental Medicine
Issue number6
Publication statusAccepted/In press - 2023


  • Asia
  • Bcl-2 inhibitors
  • BTK inhibitors
  • Chronic lymphocytic leukaemia
  • Treatment


Dive into the research topics of 'Expert consensus on the management of chronic lymphocytic leukaemia in Asia'. Together they form a unique fingerprint.

Cite this